1 |
11c-acetate |
Acetate |
- |
- |
- |
013 3件: 13, 86, 88 💬 |
2 |
[18f]fluoro-2-deoxy-2-d-glucose |
D-glucose |
1件: D00009 D00009 💬 |
- |
- |
086 2件: 86, 88 💬 |
3 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
4 |
Act-064992 |
- |
- |
- |
- |
051 5件: 51, 85, 86, 88, 210 💬 |
5 |
Act-293987 |
- |
- |
- |
- |
051 3件: 51, 86, 88 💬 |
6 |
Adempas |
- |
- |
- |
- |
051 5件: 51, 86, 88, 225, 299 💬 |
7 |
Adempas (riociguat, bay63-2521) |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 2件: 86, 88 💬 |
8 |
Adempas® |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
9 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
10 |
Ambrisentan 5 mg |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
088 1件: 88 💬 |
11 |
Ammonia |
Ammonia |
1件: D02916 D02916 💬 |
- |
- |
006 4件: 6 , 17, 86, 88 💬 |
12 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
13 |
Barnascan |
- |
- |
- |
- |
088 1件: 88 💬 |
14 |
Bay 63-2521 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
15 |
Bay 63-2521 coated tablets 0.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
16 |
Bay 63-2521 coated tablets 1 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
17 |
Bay 63-2521 coated tablets 1.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
18 |
Bay 63-2521 coated tablets 2 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
19 |
Bay 63-2521 coated tablets 2.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
20 |
Bay 63-2521 ir coated tablet 1.0 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
21 |
Bay 63-2521 ir coated tablet 1.5 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
22 |
Bay 63-2521 ir coated tablet 2.0 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
23 |
Bay 63-2521 ir coated tablet 2.5 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
24 |
Bay 63-2521 ir tablet 0.5 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
25 |
Bay 63-2521 ir tablet 1.0 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
26 |
Bay 63-2521 ir tablet 1.5 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
27 |
Bay 63-2521 ir tablet 2.0 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
28 |
Bay 63-2521 ir tablet 2.5 mg |
- |
- |
- |
- |
088 1件: 88 💬 |
29 |
Bay 63-2521 tablets 0.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
30 |
Bay 63-2521 tablets 1 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
31 |
Bay 63-2521 tablets 1.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
32 |
Bay 63-2521 tablets 2 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
33 |
Bay 63-2521 tablets 2.5 mg |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
34 |
Bay1237592 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
35 |
Behavioral: respiratory and exercise therapy |
- |
- |
- |
- |
088 1件: 88 💬 |
36 |
Behavioral: respiratory and exercise therapy with supplemental oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
088 1件: 88 💬 |
37 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
38 |
Bosentan monohydrate |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 4件: 51, 84, 86, 88 💬 |
39 |
Bpa |
- |
- |
- |
- |
088 1件: 88 💬 |
40 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
41 |
D-glucose |
D-glucose |
1件: D00009 D00009 💬 |
- |
- |
049 3件: 49, 86, 88 💬 |
42 |
Diagnostic test: endogenous thrombin potential |
Thrombin |
1件: D00090 D00090 💬 |
- |
- |
086 2件: 86, 88 💬 |
43 |
Diagnostic test: light transmission aggregometry |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
44 |
Diagnostic test: platelet function analyzer-100 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
45 |
Diagnostic test: rotational thromboelastometry |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
46 |
Edoxaban |
Edoxaban |
2件: D09546 D09546, D09710 D09710 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 2件: 46, 88 💬 |
47 |
Fludeoxyglucose |
Fludeoxyglucose |
1件: D01843 D01843 💬 |
- |
- |
034 4件: 34, 84, 85, 88 💬 |
48 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
49 |
Gsk1325760 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
50 |
Imatinib |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
51 |
Imatinib mesilate |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 3件: 13, 86, 88 💬 |
52 |
Iodine |
Iodine |
1件: D00108 D00108 💬 |
- |
- |
046 2件: 46, 88 💬 |
53 |
Jnj-67896062 / act-064992 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
54 |
Macitentan |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 5件: 51, 85, 86, 88, 210 💬 |
55 |
Macitentan 10 mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 86, 88 💬 |
56 |
Macitentan tablets |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 2件: 86, 88 💬 |
57 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
58 |
Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
59 |
Multihance |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
60 |
N-acetyl cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
013 7件: 13, 19, 34, 85, 88, 296, 310 💬 |
61 |
Ns-304 |
- |
- |
- |
- |
070 3件: 70, 86, 88 💬 |
62 |
Ns-304 placebo |
- |
- |
- |
- |
070 2件: 70, 88 💬 |
63 |
Opsumit |
- |
- |
- |
- |
086 3件: 86, 88, 210 💬 |
64 |
Opsumit® |
- |
- |
- |
- |
086 3件: 86, 88, 210 💬 |
65 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
66 |
Oxygen, liquid |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
086 2件: 86, 88 💬 |
67 |
Ph-combination therapy |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
68 |
Ph-monotherapy |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
69 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
70 |
Procedure: ballon pulmonary angioplasty |
- |
- |
- |
- |
088 1件: 88 💬 |
71 |
Procedure: balloon pulmonary angioplasty (bpa) |
- |
- |
- |
- |
088 1件: 88 💬 |
72 |
Procedure: long term oxygen therapy |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
088 1件: 88 💬 |
73 |
Procedure: no gas |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
74 |
Procedure: pulmonary endarterectomy |
- |
- |
- |
- |
088 1件: 88 💬 |
75 |
Procedure: pulmonary endarteriectomy |
- |
- |
- |
- |
088 1件: 88 💬 |
76 |
Procedure: supplemental oxygen via a mask |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
088 1件: 88 💬 |
77 |
Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3) |
Ammonia |
1件: D02916 D02916 💬 |
- |
- |
088 1件: 88 💬 |
78 |
Radiation: computed tomography lung subtraction iodine mapping |
Iodine |
1件: D00108 D00108 💬 |
- |
- |
088 1件: 88 💬 |
79 |
Remodulin |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
80 |
Remodulin (r) |
- |
- |
- |
- |
088 1件: 88 💬 |
81 |
Remodulin 10mg/ml 20ml |
- |
- |
- |
- |
088 1件: 88 💬 |
82 |
Remodulin 1mg/ml 20ml |
- |
- |
- |
- |
088 1件: 88 💬 |
83 |
Remodulin 2.5mg/ml 20ml |
- |
- |
- |
- |
088 1件: 88 💬 |
84 |
Remodulin 5mg/ml 20ml |
- |
- |
- |
- |
088 1件: 88 💬 |
85 |
Riociguat |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 6件: 51, 84, 86, 88, 225, 299 💬 |
86 |
Riociguat (adempas, bay63-2521) |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 4件: 51, 86, 88, 299 💬 |
87 |
Riociguat oral tablet |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
088 1件: 88 💬 |
88 |
Ro 47-0203 |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
89 |
Sauerstoff |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
90 |
Selexipag |
Selexipag |
1件: D09994 D09994 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 5件: 51, 70, 84, 86, 88 💬 |
91 |
Thrombin |
Thrombin |
1件: D00090 D00090 💬 |
- |
- |
086 2件: 86, 88 💬 |
92 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
93 |
Tracleer 125mg 56cpr riv. |
- |
- |
- |
- |
088 1件: 88 💬 |
94 |
Tracleer*56cpr riv 125mg |
- |
- |
- |
- |
051 3件: 51, 86, 88 💬 |
95 |
Treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 6件: 51, 84, 85, 86, 88, 210 💬 |
96 |
Treprostinil sodium |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 3件: 51, 86, 88 💬 |
97 |
Uptravi |
- |
- |
- |
- |
084 3件: 84, 86, 88 💬 |
98 |
Volibris |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
99 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |